Skip to main content

EyePoint, Inc.

EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
SEC CIK
0001314102

No open-market purchases or sales by EyePoint, Inc. insiders were filed in the last 90 days; 189 institutions reported holding it in 13F filings for Q3 2026, worth $300.9M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 20, 2026
$26.6M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, +3 vs. previous quarter
189
13F valueReported value at the end of Q3 2026
$300.9M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$31.4M
−27.5% year over year
Net income, FY2025
-$232.0M
No comparable prior period
Free cash flow, FY2025
-$243.4M
No comparable prior period
Revenue, Q3 FY2026
$756.0K
−21.7% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $232.0M (739.4% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
11.0M
Shares sold short
Change
−10.2M
−48.2% vs. previous
Days to cover
1.00
At average daily volume

Superinvestors holding EYPT, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding EYPT at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by EyePoint, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 18, 2026 (view filing)4:08 PM ETAug 18Same dayZaderej Karen L.DirectorPPurchase+10.6K$4.93+$52.3K+27.5%49.1K after
Jul 2, 2026 (view filing)4:03 PM ETJun 302 daysRibeiro RamiroChief Medical OfficerSSale−4.88K$15.01−$73.2K−100.0%0 after2 lots10b5-1
Apr 20, 2026 (view filing)Apr 173 daysRibeiro RamiroChief Medical OfficerSSale−2.44K$15.00−$36.6K−100.0%0 after10b5-1
Mar 16, 2026 (view filing)Mar 16Same dayDuker Jay S.President and CEOPPurchase+1.50K$13.15+$19.7K+1.5%100.7K after
Mar 5, 2026 (view filing)Mar 41 dayRibeiro RamiroChief Medical OfficerSSale−2.44K$17.87−$43.6K−100.0%0 after10b5-1
Feb 18, 2026 (view filing)Feb 171 dayRibeiro RamiroChief Medical OfficerSSale−2.44K$15.00−$36.6K−100.0%0 after10b5-1
Jan 7, 2026 (view filing)Jan 52 daysRibeiro RamiroChief Medical OfficerSSale−42.5K$17.10−$727.5K−100.0%0 after10b5-1
Dec 8, 2025 (view filing)4:03 PM ETDec 44 daysCormorant Asset Management, LP and 2 othersOther: Former 10% OwnerSSale−60.0K$15.70−$942.2K−0.7%8.27M after
Dec 5, 2025 (view filing)Dec 41 dayLurker NancyDirectorSSale−9.30K$15.11−$140.5K−4.3%206.5K after10b5-1
Dec 1, 2025 (view filing)Nov 26-285 daysLurker NancyDirectorSSale−700$14.95−$10.5K−0.3%215.8K after2 lots10b5-1

Top 10 13F holders, Q3 2026

See all 189 holders

The largest institutional positions in EyePoint, Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding EYPT in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Janus Henderson Group PLC9,366,332$30.5M0.01%+9,366,332New
Suvretta Capital Management, LLC8,765,000$28.7M0.79%+468,625+5.6%Added
BlackRock, Inc.7,982,162$26.1M0.00%+518,965+7.0%Added
Federated Hermes, Inc.6,934,414$22.7M0.03%+1,253,362+22.1%Added
Cormorant Asset Management, LP5,750,000$18.8M1.26%−1,250,000−17.9%Reduced
Adage Capital Partners GP, L.L.C.5,000,000$16.4M0.02%+172,208+3.6%Added
Vanguard Capital Management LLC3,668,374$12.0M0.00%+38,122+1.1%Added
Standard Life Aberdeen plc3,053,945$9.99M0.01%+1,045,143+52.0%Added
State Street Corp2,972,889$9.72M0.00%+615,344+26.1%Added
Balyasny Asset Management LLC2,150,647$7.03M0.01%+338,289+18.7%Added

Holders of 5% or more of EYPT

See all 6 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of EyePoint, Inc..

Largest holders of EYPT from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Janus Henderson Group PLC13G10.90%9.37M sharesNewSep 8, 20261 filingSep 8, 2026SEC
Tang Capital Management LLC13G9.60%8.25M sharesNewOct 27, 20261 filingOct 27, 2026SEC
BlackRock, Inc.13G/A7.70%6.43M shares+1.20 ppfrom 6.50%Oct 22, 20244 filingsJul 28, 2026SEC
Cormorant Asset Management, LP13G/A6.67%5.75M shares−1.68 ppfrom 8.35%Dec 14, 20235 filingsNov 16, 2026SEC
Franklin Resources Inc13G/A6.10%4.14M shares−1.40 ppfrom 7.50%Feb 1, 20218 filingsJan 27, 2025SEC